Introduction: Who Should Undergo Diagnostics and When

Diagnosing cardio-respiratory arrest in newborns is fundamentally different from diagnosing other medical conditions. This is not a condition that requires laboratory tests or imaging studies to identify. Instead, it demands immediate recognition through direct observation of the baby’s vital signs and physical condition. The “diagnosis” happens in real-time, often within seconds, as healthcare professionals assess whether a newborn is in crisis.

Every newborn should be carefully observed immediately after birth. Healthcare professionals trained in neonatal resuscitation must be present at every delivery to quickly identify babies who need help. According to current guidelines, approximately one out of every 10 to 20 newborns needs some assistance to begin breathing at birth, while about 1% require advanced resuscitation measures to restore heart and lung function.^[5] The need for this immediate assessment means that every baby, without exception, undergoes an initial evaluation for signs of cardio-respiratory distress right from the moment of birth.

Newborns who face higher risks include those born prematurely, especially babies with birth weights below 1,500 grams. The incidence of needing resuscitation increases significantly in these tiny infants. Other risk factors include complications during pregnancy or delivery, such as difficult births, maternal health conditions like diabetes or preeclampsia, or problems with the placenta. Babies born through emergency cesarean sections, those exposed to certain medications during labor, or those who experienced oxygen deprivation during delivery also face elevated risks.^[19]

The timing of diagnostic assessment is critical and non-negotiable. Healthcare professionals must begin their evaluation immediately at birth, without waiting for any specific timeframe or test results. This immediate assessment is the cornerstone of saving lives, as delays of even a minute or two can have serious consequences for a baby’s brain and other organs.

Diagnostic Methods: How Healthcare Professionals Identify the Condition

The primary diagnostic tool for identifying cardio-respiratory arrest in newborns is clinical observation, which means carefully watching and examining the baby. Healthcare professionals use a systematic approach to determine whether a newborn is breathing properly and has adequate heart function. This assessment begins immediately after birth and follows a specific sequence of checks.

The first and most crucial step involves checking the baby’s respiratory effort. Healthcare providers look to see if the baby is breathing normally within the first 60 seconds after birth. They observe the chest for rise and fall, listen for breathing sounds near the baby’s nose and mouth, and feel for air movement. A baby who is not breathing, breathing irregularly, or only taking occasional gasping breaths is showing clear signs of respiratory arrest.^[7]

Simultaneously, professionals assess the newborn’s heart rate. They check for a pulse and count how many times the heart beats per minute. A heart rate below 100 beats per minute in a newborn signals distress, and absent heart sounds indicate cardiac arrest. This can be done by placing a stethoscope on the baby’s chest or by feeling the pulse at the base of the umbilical cord. Speed matters enormously here—counting must be quick but accurate.

The baby’s color and muscle tone provide additional diagnostic clues. A newborn in cardio-respiratory distress may appear pale, bluish (a condition called cyanosis), or gray. The baby’s muscles may be limp and floppy, showing reduced tone, or the infant may be completely unresponsive to stimulation. Healthcare providers gently stimulate the baby and observe the response. A healthy newborn should react to touch and may cry vigorously, while a baby in arrest shows no response at all.

The position of the baby’s head and airway also becomes part of the diagnostic process. Healthcare professionals check whether the airway might be blocked by fluid, blood, mucus, or meconium (the baby’s first stool). They look inside the mouth for any obvious obstructions. For babies under one year old, the head should be positioned neutrally—not tilted too far back or forward—to keep the airway open. In older infants, a slight head tilt with chin lift helps maintain a clear breathing passage.^[21]

Another important diagnostic indicator is the baby’s responsiveness. Healthcare providers gently stimulate the newborn by rubbing the back or tapping the feet. A baby who does not respond to this stimulation, who remains limp and unmoving, is showing signs of serious distress or arrest. The absence of normal reflexes, such as crying or pulling away from touch, helps confirm the diagnosis.

The Apgar score is a standardized assessment tool used at one and five minutes after birth to describe a newborn’s overall condition. This scoring system evaluates five key areas: appearance (skin color), pulse (heart rate), grimace (reflex response), activity (muscle tone), and respiration (breathing effort). Each category receives a score from 0 to 2, with a total possible score of 10. However, it’s crucial to understand that the Apgar score is not used to guide resuscitation decisions or to determine treatment. Rather, it provides a snapshot of the baby’s condition at specific moments in time. A low Apgar score (0 to 3) indicates severe distress, but healthcare professionals do not wait for this score before beginning resuscitation efforts.^[19]

Unlike many other medical conditions, cardio-respiratory arrest in newborns cannot be diagnosed through blood tests, imaging studies, or other laboratory procedures performed beforehand. The condition reveals itself through direct, immediate observation of vital signs. There are no CT scans, MRIs, or blood draws that can diagnose an active cardio-respiratory arrest event. These diagnostic tools might be used later to investigate underlying causes or to assess organ damage, but they play no role in the initial diagnosis.

Healthcare professionals must also differentiate between respiratory arrest and cardio-respiratory arrest. In respiratory arrest, the baby stops breathing but may still have a heartbeat, at least initially. In complete cardio-respiratory arrest, both breathing and heart function have ceased. This distinction matters because it guides the urgency and type of intervention needed. Babies in respiratory arrest alone may respond to assistance with breathing, while those in full cardiac arrest require immediate chest compressions along with breathing support.

The diagnosis also involves identifying patterns that suggest impending arrest before it fully develops. Warning signs include increasingly rapid breathing (more than 60 breaths per minute), grunting sounds with each breath, flaring of the nostrils, visible pulling in of the chest muscles between ribs, or persistent bluish coloring despite oxygen support. Recognizing these early warning signs allows healthcare teams to intervene before complete arrest occurs.^[14]

Diagnostics for Clinical Trial Qualification

When it comes to enrolling newborns who have experienced cardio-respiratory arrest in clinical trials, the diagnostic criteria become more standardized and specific. Research studies require precise definitions and measurements to ensure that all participants truly have the condition being studied and to allow for meaningful comparison of results across different hospitals and populations.

For research purposes, a cardiac arrest in a newborn is typically defined as requiring at least one minute of chest compressions during resuscitation efforts. This definition helps researchers identify cases that involved significant cardio-respiratory compromise rather than brief respiratory difficulties that resolved quickly. Clinical trials studying neonatal resuscitation often use this threshold to determine which babies qualify for enrollment.^[12]

Research studies also categorize newborns based on their cardiac rhythm during arrest. The main categories include asystole (complete absence of heart electrical activity), pulseless electrical activity (electrical signals present but no effective heartbeat), ventricular fibrillation (chaotic, ineffective heart rhythm), and pulseless ventricular tachycardia (very rapid but ineffective heartbeat). Identifying which rhythm a baby exhibits requires continuous cardiac monitoring equipment that can record and display the heart’s electrical activity in real-time. This information helps researchers understand which interventions work best for different types of arrest.^[9]

Clinical trials often require documentation of specific vital sign measurements before, during, and after arrest. This includes precise recordings of heart rate, blood oxygen saturation levels measured by pulse oximetry (a device clipped to the baby’s skin that measures oxygen in the blood), blood pressure readings, and respiratory rate. Researchers need this data collected at regular, specified intervals to analyze how well different treatments work. In some studies, continuous monitoring is required for 24 hours or longer after the arrest event.

Laboratory testing becomes more relevant for clinical trial qualification. Studies may require blood samples to measure blood gas levels, which show how much oxygen and carbon dioxide are in the blood, as well as the blood’s acidity (pH level). A pH below 7.2 indicates significant acidosis, a condition where the blood becomes too acidic, often resulting from inadequate oxygen delivery to tissues. Blood tests may also measure lactate levels, a substance that builds up when cells aren’t getting enough oxygen, and glucose levels, since low blood sugar can contribute to poor outcomes.^[12]

Some research protocols require specific imaging studies after resuscitation. Brain imaging, such as ultrasound of the skull or MRI scans, may be performed to assess whether the baby suffered brain injury during the arrest. These images help researchers understand the relationship between different resuscitation techniques and neurological outcomes. However, these imaging studies are typically performed after stabilization, not during the acute arrest event.

Clinical trials may also use specialized assessment scales to categorize outcomes. The Pediatric Cerebral Performance Category Scale is commonly used in research to measure neurological function after cardiac arrest. This scale ranges from 1 (normal function) to 6 (death), with categories describing varying levels of disability. Researchers use this standardized scale to compare outcomes across different treatment approaches and to determine whether interventions improve long-term neurological health.^[13]

Timing of interventions becomes a critical data point in clinical trials. Research protocols require precise documentation of when the arrest occurred, when resuscitation efforts began, when return of spontaneous circulation was achieved (meaning the heart started beating effectively on its own), and the duration of all interventions. This detailed timeline helps researchers understand which factors influence survival and recovery.

For enrollment in clinical trials, newborns typically must meet specific age and weight criteria. Most neonatal resuscitation studies focus on babies less than 28 days old, and many specifically study those in the immediate newborn period (first few hours or days after birth). Weight thresholds may exclude extremely premature or very low birth weight babies, or alternatively, some trials specifically focus only on these high-risk populations.

Research studies also examine the underlying causes of arrest to better understand which diagnostic factors predict different outcomes. Common causes in newborns include complications from prematurity, respiratory distress syndrome (a lung condition in premature babies), meconium aspiration (breathing in stool-stained amniotic fluid), infections, congenital heart defects, or problems with the transition from fetal to newborn circulation. Clinical trials may require diagnostic tests to identify these underlying conditions, including chest X-rays, echocardiograms (ultrasound of the heart), and blood cultures to test for infection.

The quality of resuscitation efforts is also measured and documented in clinical trials. Studies examine whether chest compressions were performed at the correct depth and rate, whether breathing support delivered appropriate volumes of air, and whether medications were given at the right doses and times. Special monitoring equipment or video recording may be used to ensure accurate data collection about the resuscitation process itself.